Selected Publications
Parra NS, Hoteit MA, Rattan P, Abt P, Mahmud N.: Trends in candidate HCV NAT+ listing and associated impacts on liver transplantation waitlist outcomes Am J Transplant : 2024.
Tabrizian P, Holzner M, Ajmera V, Kim AK, Zhou K, Schnickel GT, Torosian K, Hoteit M, Marino R, Li M, Yao F, Florman SS, Schwartz ME, Mehta N: Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study J Hepatol : 2024.
Vaikunth SS, Ortega-Legaspi JM, Conrad DR, Chen S, Daugherty T, Haeffele CL, Teuteberg J, Mclean R, MacArthur JW, Woo YJ, Maeda K, Ma M, Nasirov T, Hoteit M, Hilscher MB, Wald J, Mandelbaum T, Olthoff KM, Abt PL, Atluri P, Cevasco M, Mavroudis CD, Fuller S, Lui GK, Kim YY.: Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study Clin Transplant : 2024.
Kim YY, Hoteit MA.: Turning to "Omics" in Understanding Fontan-Associated Liver Disease J Am Coll Cardiol 83 : 739-740,2024.
Kim YY, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber J, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Rosenthal BE, Hilscher M, Rychik J, Hoteit MA.: Hepatocellular carcinoma in survivors after Fontan operation: a case-control study Eur Heart J 45 : 1477-1480,2023.
Mahmud N, Yagan L, Hoteit MA, Reddy KR, Abt PL, Abu-Gazala S.: Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era Transplantation 108 : 1172-1178,2023.
ABC NEWS: Excessive drinking during the pandemic increased rates of liver disease, transplants (10/8/2023) ABC NEWS : 2023.
Ivanics T, Claasen MP, Samstein B, Emond JC, Fox AN, Pomfret E, Pomposelli J, Tabrizian P, Florman SS, Mehta N, Roberts JP, Emamaullee JA, Genyk Y, Hernandez-Alejandro R, Tomiyama K, Sasaki K, Quintini C, Nagai S, Abouljoud M, Olthoff KM, Hoteit MA, Heimbach J, Taner T, Liapakis AH, Mulligan DC, Sapisochin G, Halazun KJ.: Living Donor Liver Transplantation (LDLT) for Hepatocellular Carcinoma (HCC) within and Outside Traditional Selection Criteria: A Multicentric North American Experience Ann Surg 279 : 104-111,2023.
Natarajan B, Tabrizian P, Hoteit M, Frenette C, Parikh N, Ghaziani T, Dhanasekaran R, Guy J, Shui A, Florman S, Yao FY, Mehta N.: Downstaging Hepatocellular Carcinoma before Liver Transplantation: A Multicenter Analysis of the "All-Comers" Protocol in the MERITS-LT Consortium Am J Transplant 23 (11): 1771-1780,2023.
Tran BV, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, Florman SS, Tabrizian P, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Hoteit M, Levine MH, Cillo U, Vitale A, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Lerut J, Ciccarelli O, Nguyen MH, Melcher ML, Viveiros A, Schaefer B, Hoppe-Lotichius M, Mittler J, Nydam TL, Markmann JF, Rossi M, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Barbas AS, Agopian VG.: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium Liver Transpl 29 : 683-697,2023.
Academic Contact Information
Hospital of the University of Pennsylvania
Liver Transplant Program
3400 Spruce Street
2 Dulles
Philadelphia,
PA
19104
Phone: 215-349-5581
Patient appointments: 800-789-7366